The effects of ketamine and risperidone on eye movement control in healthy volunteers. - Wikidata - wikimedia - TriplyDB

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

http://www.wikidata.org/entity/Q30437913

about

An Overview of the Association between Schizotypy and Dopamine.Ketamine-induced brain activation in awake female nonhuman primates: a translational functional imaging model.Impaired top-down modulation of saccadic latencies in patients with schizophrenia but not in first-degree relatives Saccadic Eye Movements in Anorexia Nervosa.Cognitive and oculomotor performance in subjects with low and high schizotypy: implications for translational drug development studies.A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades.Amygdala Lesions Reduce Anxiety-like Behavior in a Human Benzodiazepine-Sensitive Approach-Avoidance Conflict Test.Sleep deprivation as an experimental model system for psychosis: Effects on smooth pursuit, prosaccades, and antisaccades.Effects of ketamine on brain function during smooth pursuit eye movements.

P2860

Q26991569-D922EA77-9BFD-4D54-9F0D-16D512338596 Q30714646-90BC433A-70A0-4011-858D-46EE02D81F8E Q35115397-3D2837B7-63EF-4EBE-BDE7-ABE9803FB9A8 Q35968500-7BABAEFB-3149-4215-948D-BA4DCFAA7AFD Q37349872-E9203560-89B2-4C95-BA65-3B14F8A5DAA2 Q38987330-B216F968-2A18-4DD5-A1F8-A31A17484ABE Q41634117-0D9D3AB7-C5F5-48C0-AFA9-6F3440C61EBD Q46395890-6D13F0DF-714F-45E4-B046-0AD2654FFEF1 Q48656998-65A92F8D-C6C8-418A-93EA-CD146E1C5F79

P2860

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

http://www.wikidata.org/entity/Q30437913

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

@ast

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

@en

type

label

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

@ast

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

@en

prefLabel

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

@ast

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

@en

P1433

Q30437913-B43A5237-953B-491F-9ED4-09CC031C51DE

P1476

Q30437913-02DBF4F8-D0A2-433C-8EE3-4D799605BD0E

P2093

Q30437913-01AA3C27-7EE0-4CA2-BAA7-D507F5A105CD

Q30437913-106BB75E-AEE7-4B33-BD15-6797B946BD51

Q30437913-6E5BE580-C248-477F-AECA-8CC54AC7F0AC

Q30437913-731332B5-6BC9-4435-8B6D-B3A401C155DB

Q30437913-ADE5CAB7-CD9E-40D5-B828-730F36041F10

Q30437913-BB42C85C-07C5-4528-AF1F-1DBBD1B4AD23

Q30437913-D62631C0-A848-4803-B8EA-3137ABA5FF86

Q30437913-F8493F6A-5F47-44E0-9D4A-3A0B109FBA19

Q30437913-FA5EEA33-1958-45DF-8CD7-32A325FF275D

P2860

Q30437913-0CD1A704-9F41-4994-A5E7-E1B14A8EAE8A

Q30437913-1201AAE6-9EF6-46FD-8BF0-92733ABA61EA

Q30437913-14766DEB-8FCD-4F07-8F80-4FDB673C522D

Q30437913-1571CD1E-AD7F-4BF6-BC35-7DE2F65C6CC3

Q30437913-1734F11F-17EB-4D9C-998B-323341703457

Q30437913-32AB461F-0F13-4729-ABF4-0680E1EF5874

Q30437913-392069A8-614B-4642-9A80-6B658F9028ED

Q30437913-3ACAFDA9-0614-4BE6-87F9-710A341BFF70

Q30437913-40F8903F-FFE2-4E5E-9B47-A689D2EA80FC

Q30437913-4B0CF7C3-BC46-4930-8567-E35E484F6FA2

P2888

Q30437913-BB8D04DD-FCF0-497C-8285-01EE6CC0BBD3

P304

Q30437913-F194E4E7-E98A-4EF0-A82A-608B8D135EF7

P31

Q30437913-292927B4-CC95-40CB-B976-04EE6EE627A4

P356

Q30437913-7FB1A71F-BF6E-441B-A7AB-54EFBF40B2A5

P478

Q30437913-12DE117B-5A73-4FFC-ABB5-536DF0223408

P50

Q30437913-2D355B47-EAA0-454F-B944-A96A04F53C28

Q30437913-3075C2C5-02A8-4455-B5D0-6307A08DC5D7

Q30437913-34816BB8-CA20-4F6E-84FF-708ADC6087FA

Q30437913-8EB79538-B865-417A-BBFD-68BAA36E4966

Q30437913-E23691EB-7538-416C-934D-F69CE55B3B90

Q30437913-E49D7A2E-619D-4EB7-BC0D-B9DC4E3A3641

Q30437913-E8CAC6E7-FD9A-410C-AECE-081387ADD704

Q30437913-F1827C54-AA3F-4FC4-B37E-E3F229A9D7DD

P577

Q30437913-99787FA3-E785-483D-90EE-AE17AFA1CB55

P5875

Q30437913-B06DD4F6-A30D-4FD5-B3BF-1328EFCA5B5C

P6179

Q30437913-3C28B46E-3C36-4976-B743-F431B03F11CD

P698

Q30437913-D07482C3-336E-4BB9-A7F0-74040DC84ABD

P932

Q30437913-04FA3802-541B-425B-81E7-E82863C2BE47

P356

P1433

Translational Psychiatry

P1476

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

@en

P2093

A Altavilla

http://www.w3.org/2001/XMLSchema#string

A Schmechtig

http://www.w3.org/2001/XMLSchema#string

G R Dawson

http://www.w3.org/2001/XMLSchema#string

J F William Deakin

http://www.w3.org/2001/XMLSchema#string

J Lees

http://www.w3.org/2001/XMLSchema#string

K J Craig

http://www.w3.org/2001/XMLSchema#string

K Weaver

http://www.w3.org/2001/XMLSchema#string

L S Wilkinson

http://www.w3.org/2001/XMLSchema#string

R Morris

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies

The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

Biomarkers for the effects of antipsychotic drugs in healthy volunteers.

Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.

P2888

P304

e334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/TP.2013.109

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Ulrich Ettinger

Steven C. R. Williams

Adam M. Perkins

Richard Smallman

Colin T Dourish

P577

2013-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259270633

http://www.w3.org/2001/XMLSchema#string

P6179

1027896467

http://www.w3.org/2001/XMLSchema#string

P698

24326395

http://www.w3.org/2001/XMLSchema#string

P932

4030328

http://www.w3.org/2001/XMLSchema#string